Purdue Pharma (English Wikipedia)

Mitchell, Jerry (January 26, 2018). "How the FDA helped pave the way for an opioid epidemic". Clarion Ledger. Jackson MS. Retrieved December 12, 2022.

cnbc.com (Global: 303^rd place; English: 191^st place)

"Purdue Pharma, Execs to Pay $634.5 Million Fine in OxyContin Case". Associated Press. May 10, 2007. Archived from the original on August 21, 2019. Retrieved September 21, 2022 – via CNBC.

cnn.com (Global: 36^th place; English: 26^th place)

cnn.com

Chris Isidore (October 21, 2020). "OxyContin maker to plead guilty to federal criminal charges, pay $8 billion, and will close the company". CNN. Retrieved October 23, 2020.
A US bankruptcy judge approved Purdue Pharma and Sacklers' $6 billion settlement agreement with states, Connecticut AG says, CNN, Lauren del Valle, March 10, 2022.
Delouya, Samantha (May 30, 2023). "Court grants Sackler family immunity in exchange for $6 billion opioid settlement". CNN.

edition.cnn.com

OxyContin maker to plead guilty to federal criminal charges, pay $8 billion, and will close the company, CNN, 18 August 2020

congress.gov (Global: 392^nd place; English: 262^nd place)

"H.R.2096 - SACKLER Act". Congress.gov. October 19, 2021. Retrieved August 22, 2023.

ct.gov (Global: 3,014^th place; English: 1,455^th place)

General, Office of the Attorney. "CT Attorney General". www.ct.gov. Archived from the original on December 19, 2006. Retrieved October 22, 2017.
General, Office of the Attorney. "CT Attorney General". www.ct.gov. Archived from the original on December 19, 2006. Retrieved October 22, 2017.

documentcloud.org (Global: 4,982^nd place; English: 2,747^th place)

Kassie McClung (The Frontier). "Oklahoma'sopioidlawsuitpetition". www.documentcloud.org. Archived from the original on March 27, 2019. Retrieved March 27, 2019.

doi.org (Global: 2^nd place; English: 2^nd place)

Van Zee, Art (February 2009). "The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy". American Journal of Public Health. 99 (2): 221–227. doi:10.2105/AJPH.2007.131714. ISSN 0090-0036. PMC 2622774. PMID 18799767.
Fudin, J.; Raouf, M.; Wegrzyn, E. L. (2016). "OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form". Journal of Pain Research. 9: 609–612. doi:10.2147/JPR.S117219. PMC 5019471. PMID 27660487. In conclusion, the oxycodone CR is well positioned to be dosed every 12 hours as initially demonstrated to and approved by the FDA in 1995.
Cicero TJ, Inciardi JA, Muñoz A (2005). "Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004". Journal of Pain. 6 (10): 662–72. doi:10.1016/j.jpain.2005.05.004. PMID 16202959.

domain-b.com (Global: low place; English: low place)

"domain-b.com: Purdue Pharma fined $634 million for OxyContin deaths; executives punished". www.domain-b.com. July 22, 2007. Archived from the original on February 6, 2010. Retrieved October 22, 2017.

esquire.com (Global: 893^rd place; English: 582^nd place)

Glazek, Christopher (October 16, 2017). "The Secretive Family Making Billions From the Opioid Crisis". Esquire. Archived from the original on September 20, 2019. Retrieved September 21, 2019.

fiercepharma.com (Global: low place; English: 8,341^st place)

Becker, Zoey (May 31, 2023). "With court's blessing, billionaire Sackler family awarded legal protections in Purdue's $6B settlement". Fierce Pharma.

finance.yahoo.com (Global: 894^th place; English: 567^th place)

Balsamo, Michael; Mulvihill, Geoff (October 21, 2020). "US officials: OxyContin maker to plead to 3 criminal charges". finance.yahoo.com. Retrieved October 21, 2020.

ft.com (Global: 193^rd place; English: 127^th place)

"Opioid maker Purdue Pharma agrees $8bn US settlement". Retrieved October 23, 2020.
Crow, David (September 9, 2018). "Billionaire Sackler family owns second opioid drugmaker". Financial Times. Archived from the original on September 15, 2018. Retrieved September 15, 2018.
David Crowe (September 8, 2018). "What next for the Sacklers? A pharma dynasty under siege". Financial Times. Archived from the original on March 27, 2019. Retrieved February 24, 2019.

genengnews.com (Global: low place; English: 6,199^th place)

"Purdue Pharma Acquires TrkA Inhibitor Program for Up to $213M+ - GEN". GEN. September 8, 2015. Archived from the original on October 23, 2017. Retrieved October 22, 2017.

healthsense-uk.org (Global: low place; English: low place)

Richmond, Caroline (April 2023). "A rose by any other name". HealthSense. ISSN 3029-0244. Retrieved July 28, 2026.

heraldnet.com (Global: 4,950^th place; English: 2,443^rd place)

Scott North (February 20, 2017), "Everett's suit against OxyContin maker moves to federal court", Everett Herald, archived from the original on February 28, 2017, retrieved May 31, 2017

hilltopmonitor.com (Global: low place; English: low place)

"OxyContin drugmaker Purdue files for bankruptcy". hilltopmonitor.com. Archived from the original on March 5, 2021. Retrieved September 19, 2019.

hyperallergic.com (Global: 4,983^rd place; English: 2,722^nd place)

"Elizabeth A. Sackler Supports Nan Goldin in Her Campaign Against OxyContin". Hyperallergic. January 22, 2018. Archived from the original on January 23, 2018. Retrieved January 23, 2018.

justice.gov (Global: 884^th place; English: 477^th place)

"Office of Public Affairs | Opioid Manufacturer Purdue Pharma Sentenced for Fraud and Kickback Conspiracies | United States Department of Justice". www.justice.gov. April 28, 2026. Retrieved May 1, 2026.
"Opioid Manufacturer Purdue Pharma Sentenced for Fraud and Kickback Conspiracies". www.justice.gov. April 28, 2026. Retrieved May 1, 2026.{{cite web}}: CS1 maint: url-status (link)

knoapharma.com (Global: low place; English: low place)

"About Us | Knoa Pharma". Knoa Pharma. Archived from the original on June 6, 2026. Retrieved August 1, 2026.

latimes.com (Global: 32^nd place; English: 21^st place)

Harriet, Ryan; Girion, Lisa; Glover, Scott (May 5, 2016). "'You want a description of hell?' OxyContin's 12-hour problem". Los Angeles Times. Archived from the original on January 24, 2018. Retrieved October 18, 2017. This is an in-depth series.
'You Want A Description Of Hell?' Oxycontin's 12-Hour Problem, Los Angeles Times, 5 May 2016
Harriet Ryan (January 19, 2017), "City devastated by OxyContin use sues Purdue Pharma, claims drugmaker put profits over citizens' welfare", Los Angeles Times, archived from the original on June 1, 2017, retrieved May 31, 2017

mass.gov (Global: 4,269^th place; English: 2,127^th place)

Internal memorandum, Kirk Ogrosky
Internal Memorandum, Kirk Ogrosky

mysanantonio.com (Global: 3,758^th place; English: 1,989^th place)

Paul Schott (March 2019). "FDA approves Purdue Pharma subsidiary's ADHD drug". Mysa. Archived from the original on March 6, 2019. Retrieved March 5, 2019.

nbcnews.com (Global: 156^th place; English: 101^st place)

Strickler, Laura (September 9, 2019). "Opioid talks break down; Purdue owners balk at paying $4.5 billion". Associated Press. Archived from the original on September 21, 2019. Retrieved September 21, 2022 – via NBC News.
First it sold Oxycontin, then pharma company saw market for anti-addiction drug, suit says, NBC News, 2 February 2019.
"Purdue Pharma offers $10-12B to settle 2,000+ opioid lawsuits". NBC News. August 27, 2019. Archived from the original on August 27, 2019. Retrieved August 27, 2019.
"They're the first family of pharma. And now they're being sued". NBC News. June 16, 2018. Archived from the original on September 11, 2019. Retrieved September 19, 2019.
"N.Y. officials: We found $1 billion in Sackler family wire transfers". NBC News. September 14, 2019. Archived from the original on September 20, 2019. Retrieved September 21, 2019.

nber.org (Global: 3,811^th place; English: 2,424^th place)

Evans, William. "HOW THE REFORMULATION OF OXYCONTIN IGNITED THE HEROIN EPIDEMIC" (PDF). NATIONAL BUREAU OF ECONOMIC RESEARCH. Retrieved March 17, 2026.

newyorker.com (Global: 191^st place; English: 122^nd place)

Keefe, Patrick Radden (October 23, 2017). "The Family That Built an Empire of Pain". The New Yorker. ISSN 0028-792X. Archived from the original on January 22, 2018. Retrieved January 19, 2018.
The Family That Built an Empire of Pain, New Yorker, 23 October 2017
Keefe, Patrick Radden (October 2017). "The Family That Built an Empire of Pain: The Sackler dynasty's ruthless marketing of painkillers has generated billions of dollars—and millions of addicts". The New Yorker. A Reporter at Large. Archived from the original on January 22, 2018. Retrieved October 26, 2017. According to Forbes, the Sacklers are now one of America's richest families, with a collective net worth of thirteen billion dollars—more than the Rockefellers or the Mellons... While the Sacklers are interviewed regularly on the subject of their generosity, they almost never speak publicly about the family business, Purdue Pharma—a privately held company, based in Stamford, Connecticut, that developed the prescription painkiller OxyContin. Indepth-analysis
The Family that Built an Empire of pain. The New Yorker, 23 October 2017
"The Family That Built an Empire of Pain". The New Yorker. October 23, 2017. Archived from the original on January 22, 2018. Retrieved October 26, 2017.
Keefe, Patrick Radden (October 23, 2017). "The Family That Built an Empire of Pain". The New Yorker. Archived from the original on January 22, 2018. Retrieved March 27, 2019 – via www.newyorker.com.
"New Yorker Sackler Article". newyorker.com. October 23, 2017. Archived from the original on January 22, 2018. Retrieved October 17, 2018.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Caleb, Alexander. "Rethinking opioid prescribing to protect patient safety and public health". PubMed. Retrieved March 13, 2026.
Van Zee, Art (February 2009). "The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy". American Journal of Public Health. 99 (2): 221–227. doi:10.2105/AJPH.2007.131714. ISSN 0090-0036. PMC 2622774. PMID 18799767.
Fudin, J.; Raouf, M.; Wegrzyn, E. L. (2016). "OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form". Journal of Pain Research. 9: 609–612. doi:10.2147/JPR.S117219. PMC 5019471. PMID 27660487. In conclusion, the oxycodone CR is well positioned to be dosed every 12 hours as initially demonstrated to and approved by the FDA in 1995.
Hirsch R (2017). "The Opioid Epidemic: It's Time to Place Blame Where It Belongs". Missouri Medicine. 114 (2): 82–90. PMC 6140023. PMID 30228543.
Cicero TJ, Inciardi JA, Muñoz A (2005). "Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004". Journal of Pain. 6 (10): 662–72. doi:10.1016/j.jpain.2005.05.004. PMID 16202959.

ncbi.nlm.nih.gov

Van Zee, Art (February 2009). "The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy". American Journal of Public Health. 99 (2): 221–227. doi:10.2105/AJPH.2007.131714. ISSN 0090-0036. PMC 2622774. PMID 18799767.
Fudin, J.; Raouf, M.; Wegrzyn, E. L. (2016). "OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form". Journal of Pain Research. 9: 609–612. doi:10.2147/JPR.S117219. PMC 5019471. PMID 27660487. In conclusion, the oxycodone CR is well positioned to be dosed every 12 hours as initially demonstrated to and approved by the FDA in 1995.
Hirsch R (2017). "The Opioid Epidemic: It's Time to Place Blame Where It Belongs". Missouri Medicine. 114 (2): 82–90. PMC 6140023. PMID 30228543.

no-more-tears.org (Global: low place; English: low place)

Janssen (December 9, 1998). "Supply Agreement" (PDF). PF Laboratories contract. Retrieved May 13, 2025.
Whoriskey, Peter (March 26, 2020). "How Johnson & Johnson companies used a 'super poppy' to make narcotics for America's most abused opioid pills" (PDF). The Washington Post. Retrieved May 13, 2025.

npr.org (Global: 114^th place; English: 75^th place)

Mann, Brian (September 11, 2019). "Purdue Pharma Reaches Tentative Deal To Settle Thousands Of Opioid Lawsuits". NPR. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
"U.S. City Sues OxyContin Maker For Contributing To Opioid Crisis", Morning Edition, NPR, February 3, 2017, archived from the original on March 13, 2018, retrieved April 5, 2018
Gonzales, Richard (September 13, 2019). "New York AG Says Sacklers Transferred $1B From Pharma Accounts To Themselves". NPR. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
Mann, Brian (May 3, 2021). "Sackler Family Bid For Opioid Immunity Is Fought By 24 States And D.C.: NPR". NPR. NPR. Retrieved May 5, 2021.
Mann, Brian (March 3, 2022). "Purdue Pharma and the Sackler family reach $6 billion OxyContin settlement: NPR". npr.org. Retrieved June 29, 2024.

ny.gov (Global: 1,386^th place; English: 642^nd place)

ag.ny.gov

"Attorney General James Announces Shutdown of Opioid Manufacturer Purdue Pharma". ag.ny.gov. May 1, 2026. Retrieved August 1, 2026.

nytimes.com (Global: 7^th place; English: 7^th place)

Roberts, Sam (July 19, 2017). "Opinion - Raymond Sackler, Psychopharmacology Pioneer and Philanthropist, Dies at 97". The New York Times. Archived from the original on December 28, 2017. Retrieved February 11, 2018.
Hoffman, Jan; Walsh, Mary Williams (September 15, 2019). "Purdue Pharma, Maker of OxyContin, Files for Bankruptcy". The New York Times. ISSN 0362-4331. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
Meier, Barry (May 10, 2007). "In Guilty Plea, OxyContin Maker to Pay $600 Million". The New York Times. Archived from the original on October 27, 2017. Retrieved October 26, 2017.
"McKinsey Advised Purdue Pharma How to 'Turbocharge' Opioid Sales, Lawsuit Says". The New York Times. February 1, 2019.
"McKinsey Proposed Paying Pharmacy Companies Rebates for OxyContin Overdoses". The New York Times. November 27, 2020.
"McKinsey Proposed Paying Pharmacy Companies Rebates for OxyContin Overdoses". The New York Times. November 27, 2020.
"McKinsey Settles for Nearly $600 Million Over Role in Opioid Crisis". The New York Times. February 3, 2021.
"McKinsey Settles for Nearly $600 Million Over Role in Opioid Crisis". The New York Times. February 3, 2021.
Meier, Barry (May 29, 2018). "Origins of an Epidemic: Purdue Pharma Knew Its Opioids Were Widely Abused". The New York Times. Archived from the original on May 30, 2018. Retrieved May 30, 2018.
Barry Meier (May 11, 2007). "In Guilty Plea, OxyContin Maker to Pay $600 Million". The New York Times. Archived from the original on June 11, 2015.
Hoffman, Jan (March 26, 2019). "Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid Lawsuit". The New York Times. ISSN 0362-4331. Archived from the original on March 27, 2019. Retrieved March 27, 2019.
Hoffman, Jan (August 27, 2019). "Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal". The New York Times. Archived from the original on August 28, 2019. Retrieved August 28, 2019.
Hoffman, Jan; Hakim, Danny (December 16, 2019). "Purdue Pharma Payments to Sackler Family Soared Amid Opioid Crisis". The New York Times. Archived from the original on December 18, 2019. Retrieved December 18, 2019.
Hoffman, Jan (December 17, 2021). "Judge Overturns Purdue Pharma's Opioid Settlement". The New York Times. ISSN 0362-4331. Retrieved January 1, 2022.
VanSickle, Abbie (August 10, 2023). "Supreme Court Pauses Purdue Pharma Bankruptcy Deal". The New York Times. Retrieved August 10, 2023.
VanSickle, Abbie (June 27, 2024). "Supreme Court Jeopardizes Opioid Deal, Rejecting Protections for Sacklers". New York TImes. Retrieved August 21, 2024.

opiateaddictionsupport.com (Global: low place; English: low place)

"FRONTLINE Documentary "Chasing Heroin" Investigates the Opioid Epidemic". February 27, 2016. Archived from the original on March 7, 2016. Retrieved March 4, 2016.

purdue.edu (Global: 1,391^st place; English: 979^th place)

Service, Purdue News. "Purdue University statement re: Purdue Pharma". www.purdue.edu. Archived from the original on September 21, 2019. Retrieved September 21, 2019.

purduepharma.com (Global: low place; English: low place)

"About Purdue Pharma L.P." www.purduepharma.com. Archived from the original on September 6, 2015. Retrieved October 22, 2017.
"About Purdue Pharma L.P." Archived from the original on September 6, 2015. Retrieved September 8, 2015.

reuters.com (Global: 38^th place; English: 30^th place)

"OxyContin maker Purdue Pharma files for bankruptcy protection". Reuters. September 17, 2019. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
Knauth, Dietrich (July 25, 2023). "Purdue Pharma bankruptcy can proceed despite potential US Supreme Court appeal". Reuters. Retrieved August 4, 2023.
Bellon, Tina (May 15, 2018). "U.S. state lawsuits against Purdue Pharma over opioid epidemic mount". Reuters. Archived from the original on June 14, 2018. Retrieved June 5, 2018.
Kruzel, John; Chung, Andrew (August 10, 2023). "US Supreme Court to scrutinize Purdue Pharma bankruptcy settlement". Reuters. Retrieved August 10, 2023.

sackleract.org (Global: low place; English: low place)

"SACKLER ACT". sackleract.org. Archived from the original on June 29, 2021. Retrieved June 29, 2021.

semafor.com (Global: low place; English: 6,209^th place)

At least 20 institutions have now dropped the Sackler name, Semafor, 17 May 2023.

si.edu (Global: 256^th place; English: 197^th place)

Smithsonian Institution: Gray's Glycerine Tonic Comp. description

slate.com (Global: 409^th place; English: 260^th place)

Slate, The Sacklers Get to Walk Away, Mary Harris, March 21, 2022. The interview with NPR's Brian Mann is "condensed and edited for clarity."

stamfordadvocate.com (Global: low place; English: 6,249^th place)

Schott, Paul (June 22, 2017). "Purdue Pharma appoints new CEO". Stamford Advocate. Archived from the original on May 21, 2019. Retrieved May 22, 2019.
Schott, Paul (April 7, 2019). "Sacklers quit Purdue Pharma board amid shifts for OxyContin maker". Stamford Advocate. Archived from the original on May 28, 2019. Retrieved May 22, 2019.

statista.com (Global: 1,214^th place; English: 1,277^th place)

"Number of individuals who consumed Heroin during the past year in the United States from 2002 to 2024, by age". Statista. Retrieved March 13, 2026.

statnews.com (Global: 7,413^th place; English: 4,542^nd place)

The man at the center of the secret OxyContin files, STAT, 12 May 2016

thefix.com (Global: low place; English: low place)

Victoria Kim (November 3, 2017). "The Secretive Billionaire Family Behind The Rise Of Oxycontin". The Fix. Archived from the original on February 23, 2019. Retrieved February 22, 2019.

theguardian.com (Global: 16^th place; English: 11^th place)

Purdue Pharma escaped serious charges over opioid in 2006, memo shows, The Guardian, 19 August 2020
"Sackler Blood Money disgraces museums". The Guardian. February 16, 2018. Archived from the original on October 17, 2018. Retrieved October 17, 2018.

thehill.com (Global: 469^th place; English: 252^nd place)

Williams, Jordan (March 19, 2021). "Democrats unveil bill to prevent members of the Sackler family from evading lawsuits through bankruptcy". The Hill. Retrieved May 17, 2021.
"Maloney presses for action on bill focused on accountability in opioid crisis". The Hill. June 8, 2021. Retrieved June 29, 2021.

uconn.edu (Global: 5,263^rd place; English: 3,154^th place)

opencommons.uconn.edu

Evaluating Nondebtor Releases: How Purdue PharmaEmphasizes the Need for Congress to Resolve the Decades-Long Debate, Connecticut Law review, June 2023

usatoday.com (Global: 55^th place; English: 36^th place)

usatoday.com

Sue Lindsey, (May 11, 2007) OxyContin Maker, Execs Guilty of Deceit Archived 2012-09-11 at the Wayback Machine USA Today reproducing and Associated Press report
Moritz, John C. "6 states sue maker of OxyContin as they battle expenses, human costs of opioid crisis". USA Today. Corpus Christi (Texas) Caller Times. Archived from the original on May 28, 2018. Retrieved June 5, 2018.
Mulvihill, Geoff (September 15, 2019). "OxyContin maker Purdue Pharma files for bankruptcy as part of opioids settlement". USA Today. Archived from the original on September 16, 2019. Retrieved September 16, 2019.

usatoday30.usatoday.com

"Kentucky sues makers of OxyContin". USA Today. Archived from the original on August 14, 2016. Retrieved October 22, 2017.

wbur.org (Global: 3,044^th place; English: 1,526^th place)

WBUR Boston, Massachusetts, Suit: Patients Who Used Purdue's Discount Cards Were More Likely To Get Hooked On OxyContin, Christine Willmsen, Feb. 1, 2019. This article includes graph which shows with and without OxyContin "Savings Card."

web.archive.org (Global: 1^st place; English: 1^st place)

Glazek, Christopher (October 16, 2017). "The Secretive Family Making Billions From the Opioid Crisis". Esquire. Archived from the original on September 20, 2019. Retrieved September 21, 2019.
Keefe, Patrick Radden (October 23, 2017). "The Family That Built an Empire of Pain". The New Yorker. ISSN 0028-792X. Archived from the original on January 22, 2018. Retrieved January 19, 2018.
Roberts, Sam (July 19, 2017). "Opinion - Raymond Sackler, Psychopharmacology Pioneer and Philanthropist, Dies at 97". The New York Times. Archived from the original on December 28, 2017. Retrieved February 11, 2018.
"Purdue Pharma, Execs to Pay $634.5 Million Fine in OxyContin Case". Associated Press. May 10, 2007. Archived from the original on August 21, 2019. Retrieved September 21, 2022 – via CNBC.
Strickler, Laura (September 9, 2019). "Opioid talks break down; Purdue owners balk at paying $4.5 billion". Associated Press. Archived from the original on September 21, 2019. Retrieved September 21, 2022 – via NBC News.
Mann, Brian (September 11, 2019). "Purdue Pharma Reaches Tentative Deal To Settle Thousands Of Opioid Lawsuits". NPR. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
"OxyContin maker Purdue Pharma files for bankruptcy protection". Reuters. September 17, 2019. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
Hoffman, Jan; Walsh, Mary Williams (September 15, 2019). "Purdue Pharma, Maker of OxyContin, Files for Bankruptcy". The New York Times. ISSN 0362-4331. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
"About Us | Knoa Pharma". Knoa Pharma. Archived from the original on June 6, 2026. Retrieved August 1, 2026.
Service, Purdue News. "Purdue University statement re: Purdue Pharma". www.purdue.edu. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
"About Purdue Pharma L.P." www.purduepharma.com. Archived from the original on September 6, 2015. Retrieved October 22, 2017.
"Elizabeth A. Sackler Supports Nan Goldin in Her Campaign Against OxyContin". Hyperallergic. January 22, 2018. Archived from the original on January 23, 2018. Retrieved January 23, 2018.
"About Purdue Pharma L.P." Archived from the original on September 6, 2015. Retrieved September 8, 2015.
"Purdue Pharma Acquires TrkA Inhibitor Program for Up to $213M+ - GEN". GEN. September 8, 2015. Archived from the original on October 23, 2017. Retrieved October 22, 2017.
Meier, Barry (May 10, 2007). "In Guilty Plea, OxyContin Maker to Pay $600 Million". The New York Times. Archived from the original on October 27, 2017. Retrieved October 26, 2017.
Harriet, Ryan; Girion, Lisa; Glover, Scott (May 5, 2016). "'You want a description of hell?' OxyContin's 12-hour problem". Los Angeles Times. Archived from the original on January 24, 2018. Retrieved October 18, 2017. This is an in-depth series.
Keefe, Patrick Radden (October 2017). "The Family That Built an Empire of Pain: The Sackler dynasty's ruthless marketing of painkillers has generated billions of dollars—and millions of addicts". The New Yorker. A Reporter at Large. Archived from the original on January 22, 2018. Retrieved October 26, 2017. According to Forbes, the Sacklers are now one of America's richest families, with a collective net worth of thirteen billion dollars—more than the Rockefellers or the Mellons... While the Sacklers are interviewed regularly on the subject of their generosity, they almost never speak publicly about the family business, Purdue Pharma—a privately held company, based in Stamford, Connecticut, that developed the prescription painkiller OxyContin. Indepth-analysis
"Sackler family 'funnelled cash into Swiss banks'". BBC News. September 14, 2019. Archived from the original on September 16, 2019. Retrieved September 19, 2019.
Crow, David (September 9, 2018). "Billionaire Sackler family owns second opioid drugmaker". Financial Times. Archived from the original on September 15, 2018. Retrieved September 15, 2018.
Victoria Kim (November 3, 2017). "The Secretive Billionaire Family Behind The Rise Of Oxycontin". The Fix. Archived from the original on February 23, 2019. Retrieved February 22, 2019.
Paul Schott (March 2019). "FDA approves Purdue Pharma subsidiary's ADHD drug". Mysa. Archived from the original on March 6, 2019. Retrieved March 5, 2019.
Schott, Paul (June 22, 2017). "Purdue Pharma appoints new CEO". Stamford Advocate. Archived from the original on May 21, 2019. Retrieved May 22, 2019.
David Crowe (September 8, 2018). "What next for the Sacklers? A pharma dynasty under siege". Financial Times. Archived from the original on March 27, 2019. Retrieved February 24, 2019.
Schott, Paul (April 7, 2019). "Sacklers quit Purdue Pharma board amid shifts for OxyContin maker". Stamford Advocate. Archived from the original on May 28, 2019. Retrieved May 22, 2019.
2007 US v. Purdue Frederick [i.bnet.com/blogs/purdue-agreed-facts.pdf plea agreement order] for the conviction of Purdue Frederick and its employees Michael Friedman, Howard Udell, and Paul Goldenbaum. Archived on February 1, 2022, retrieved ebenda.
"The Family That Built an Empire of Pain". The New Yorker. October 23, 2017. Archived from the original on January 22, 2018. Retrieved October 26, 2017.
"FRONTLINE Documentary "Chasing Heroin" Investigates the Opioid Epidemic". February 27, 2016. Archived from the original on March 7, 2016. Retrieved March 4, 2016.
Keefe, Patrick Radden (October 23, 2017). "The Family That Built an Empire of Pain". The New Yorker. Archived from the original on January 22, 2018. Retrieved March 27, 2019 – via www.newyorker.com.
Smith, Jason. "Kingpins: OxyContin, Heroin, and the Sackler-Sinaloa Connection". Archived from the original on March 7, 2016. Retrieved March 4, 2016.
Meier, Barry (May 29, 2018). "Origins of an Epidemic: Purdue Pharma Knew Its Opioids Were Widely Abused". The New York Times. Archived from the original on May 30, 2018. Retrieved May 30, 2018.
General, Office of the Attorney. "CT Attorney General". www.ct.gov. Archived from the original on December 19, 2006. Retrieved October 22, 2017.
General, Office of the Attorney. "CT Attorney General". www.ct.gov. Archived from the original on December 19, 2006. Retrieved October 22, 2017.
Sue Lindsey, (May 11, 2007) OxyContin Maker, Execs Guilty of Deceit Archived 2012-09-11 at the Wayback Machine USA Today reproducing and Associated Press report
Barry Meier (May 11, 2007). "In Guilty Plea, OxyContin Maker to Pay $600 Million". The New York Times. Archived from the original on June 11, 2015.
"domain-b.com: Purdue Pharma fined $634 million for OxyContin deaths; executives punished". www.domain-b.com. July 22, 2007. Archived from the original on February 6, 2010. Retrieved October 22, 2017.
"Kentucky sues makers of OxyContin". USA Today. Archived from the original on August 14, 2016. Retrieved October 22, 2017.
"Kentucky settles lawsuit with OxyContin maker for $24 million". CBS News. December 23, 2015. Archived from the original on April 30, 2016. Retrieved May 2, 2016.
Harriet Ryan (January 19, 2017), "City devastated by OxyContin use sues Purdue Pharma, claims drugmaker put profits over citizens' welfare", Los Angeles Times, archived from the original on June 1, 2017, retrieved May 31, 2017
Scott North (February 20, 2017), "Everett's suit against OxyContin maker moves to federal court", Everett Herald, archived from the original on February 28, 2017, retrieved May 31, 2017
"U.S. City Sues OxyContin Maker For Contributing To Opioid Crisis", Morning Edition, NPR, February 3, 2017, archived from the original on March 13, 2018, retrieved April 5, 2018
Bellon, Tina (May 15, 2018). "U.S. state lawsuits against Purdue Pharma over opioid epidemic mount". Reuters. Archived from the original on June 14, 2018. Retrieved June 5, 2018.
Moritz, John C. "6 states sue maker of OxyContin as they battle expenses, human costs of opioid crisis". USA Today. Corpus Christi (Texas) Caller Times. Archived from the original on May 28, 2018. Retrieved June 5, 2018.
"Family behind OxyContin maker engineered opioid crisis, Massachusetts AG says". CBS News. January 24, 2019. Archived from the original on January 27, 2019. Retrieved January 28, 2019.
Kassie McClung (The Frontier). "Oklahoma'sopioidlawsuitpetition". www.documentcloud.org. Archived from the original on March 27, 2019. Retrieved March 27, 2019.
Hoffman, Jan (March 26, 2019). "Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid Lawsuit". The New York Times. ISSN 0362-4331. Archived from the original on March 27, 2019. Retrieved March 27, 2019.
"Sackler drug firm settles opioid lawsuit". BBC News. March 26, 2019. Archived from the original on March 28, 2019. Retrieved March 28, 2019.
"New Yorker Sackler Article". newyorker.com. October 23, 2017. Archived from the original on January 22, 2018. Retrieved October 17, 2018.
"Sackler Blood Money disgraces museums". The Guardian. February 16, 2018. Archived from the original on October 17, 2018. Retrieved October 17, 2018.
"Artists Protest Sackler Family Through Museums That Bear Their Name". Bloomberg. March 6, 2019. Archived from the original on April 16, 2019. Retrieved April 16, 2019.
"Purdue Pharma offers $10-12B to settle 2,000+ opioid lawsuits". NBC News. August 27, 2019. Archived from the original on August 27, 2019. Retrieved August 27, 2019.
Hoffman, Jan (August 27, 2019). "Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal". The New York Times. Archived from the original on August 28, 2019. Retrieved August 28, 2019.
Mulvihill, Geoff (September 15, 2019). "OxyContin maker Purdue Pharma files for bankruptcy as part of opioids settlement". USA Today. Archived from the original on September 16, 2019. Retrieved September 16, 2019.
"They're the first family of pharma. And now they're being sued". NBC News. June 16, 2018. Archived from the original on September 11, 2019. Retrieved September 19, 2019.
"OxyContin drugmaker Purdue files for bankruptcy". hilltopmonitor.com. Archived from the original on March 5, 2021. Retrieved September 19, 2019.
Gonzales, Richard (September 13, 2019). "New York AG Says Sacklers Transferred $1B From Pharma Accounts To Themselves". NPR. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
"N.Y. officials: We found $1 billion in Sackler family wire transfers". NBC News. September 14, 2019. Archived from the original on September 20, 2019. Retrieved September 21, 2019.
Hoffman, Jan; Hakim, Danny (December 16, 2019). "Purdue Pharma Payments to Sackler Family Soared Amid Opioid Crisis". The New York Times. Archived from the original on December 18, 2019. Retrieved December 18, 2019.
"SACKLER ACT". sackleract.org. Archived from the original on June 29, 2021. Retrieved June 29, 2021.

worldcat.org (Global: 4^th place; English: 4^th place)

search.worldcat.org

Keefe, Patrick Radden (October 23, 2017). "The Family That Built an Empire of Pain". The New Yorker. ISSN 0028-792X. Archived from the original on January 22, 2018. Retrieved January 19, 2018.
Van Zee, Art (February 2009). "The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy". American Journal of Public Health. 99 (2): 221–227. doi:10.2105/AJPH.2007.131714. ISSN 0090-0036. PMC 2622774. PMID 18799767.
Hoffman, Jan; Walsh, Mary Williams (September 15, 2019). "Purdue Pharma, Maker of OxyContin, Files for Bankruptcy". The New York Times. ISSN 0362-4331. Archived from the original on September 21, 2019. Retrieved September 21, 2019.
Keefe, Patrick Radden (2021). Empire of Pain: The Secret History of the Sackler Dynasty (First ed.). London: Picador. pp. 272–284. ISBN 978-1-5290-6307-3. OCLC 1249442332.
Hoffman, Jan (March 26, 2019). "Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid Lawsuit". The New York Times. ISSN 0362-4331. Archived from the original on March 27, 2019. Retrieved March 27, 2019.
Richmond, Caroline (April 2023). "A rose by any other name". HealthSense. ISSN 3029-0244. Retrieved July 28, 2026.
Hoffman, Jan (December 17, 2021). "Judge Overturns Purdue Pharma's Opioid Settlement". The New York Times. ISSN 0362-4331. Retrieved January 1, 2022.

Purdue Pharma (English Wikipedia)

addictionunscripted.com (Global: low place; English: low place)

apnews.com (Global: 101st place; English: 62nd place)

archive.org (Global: 6th place; English: 6th place)

bbc.com (Global: 26th place; English: 23rd place)

bloomberg.com (Global: 118th place; English: 85th place)

cbsnews.com (Global: 136th place; English: 93rd place)

clarionledger.com (Global: 4,589th place; English: 2,182nd place)

cnbc.com (Global: 303rd place; English: 191st place)

cnn.com (Global: 36th place; English: 26th place)

cnn.com

edition.cnn.com

congress.gov (Global: 392nd place; English: 262nd place)

ct.gov (Global: 3,014th place; English: 1,455th place)

documentcloud.org (Global: 4,982nd place; English: 2,747th place)

doi.org (Global: 2nd place; English: 2nd place)

domain-b.com (Global: low place; English: low place)

esquire.com (Global: 893rd place; English: 582nd place)

fiercepharma.com (Global: low place; English: 8,341st place)

finance.yahoo.com (Global: 894th place; English: 567th place)

ft.com (Global: 193rd place; English: 127th place)

genengnews.com (Global: low place; English: 6,199th place)

healthsense-uk.org (Global: low place; English: low place)

heraldnet.com (Global: 4,950th place; English: 2,443rd place)

hilltopmonitor.com (Global: low place; English: low place)

hyperallergic.com (Global: 4,983rd place; English: 2,722nd place)

justice.gov (Global: 884th place; English: 477th place)

knoapharma.com (Global: low place; English: low place)

latimes.com (Global: 32nd place; English: 21st place)

mass.gov (Global: 4,269th place; English: 2,127th place)

mysanantonio.com (Global: 3,758th place; English: 1,989th place)

nbcnews.com (Global: 156th place; English: 101st place)

nber.org (Global: 3,811th place; English: 2,424th place)

newyorker.com (Global: 191st place; English: 122nd place)

nih.gov (Global: 5th place; English: 5th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

no-more-tears.org (Global: low place; English: low place)

npr.org (Global: 114th place; English: 75th place)

ny.gov (Global: 1,386th place; English: 642nd place)

ag.ny.gov

nytimes.com (Global: 7th place; English: 7th place)

opiateaddictionsupport.com (Global: low place; English: low place)

purdue.edu (Global: 1,391st place; English: 979th place)

purduepharma.com (Global: low place; English: low place)

reuters.com (Global: 38th place; English: 30th place)

sackleract.org (Global: low place; English: low place)

semafor.com (Global: low place; English: 6,209th place)

si.edu (Global: 256th place; English: 197th place)

slate.com (Global: 409th place; English: 260th place)

stamfordadvocate.com (Global: low place; English: 6,249th place)

statista.com (Global: 1,214th place; English: 1,277th place)

statnews.com (Global: 7,413th place; English: 4,542nd place)

thefix.com (Global: low place; English: low place)

theguardian.com (Global: 16th place; English: 11th place)

thehill.com (Global: 469th place; English: 252nd place)

uconn.edu (Global: 5,263rd place; English: 3,154th place)

opencommons.uconn.edu

usatoday.com (Global: 55th place; English: 36th place)

usatoday.com

usatoday30.usatoday.com

wbur.org (Global: 3,044th place; English: 1,526th place)

web.archive.org (Global: 1st place; English: 1st place)

worldcat.org (Global: 4th place; English: 4th place)

search.worldcat.org

apnews.com (Global: 101^st place; English: 62^nd place)

archive.org (Global: 6^th place; English: 6^th place)

bbc.com (Global: 26^th place; English: 23^rd place)

bloomberg.com (Global: 118^th place; English: 85^th place)

cbsnews.com (Global: 136^th place; English: 93^rd place)

clarionledger.com (Global: 4,589^th place; English: 2,182^nd place)

cnbc.com (Global: 303^rd place; English: 191^st place)

cnn.com (Global: 36^th place; English: 26^th place)

congress.gov (Global: 392^nd place; English: 262^nd place)

ct.gov (Global: 3,014^th place; English: 1,455^th place)

documentcloud.org (Global: 4,982^nd place; English: 2,747^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

esquire.com (Global: 893^rd place; English: 582^nd place)

fiercepharma.com (Global: low place; English: 8,341^st place)

finance.yahoo.com (Global: 894^th place; English: 567^th place)

ft.com (Global: 193^rd place; English: 127^th place)

genengnews.com (Global: low place; English: 6,199^th place)

heraldnet.com (Global: 4,950^th place; English: 2,443^rd place)

hyperallergic.com (Global: 4,983^rd place; English: 2,722^nd place)

justice.gov (Global: 884^th place; English: 477^th place)

latimes.com (Global: 32^nd place; English: 21^st place)

mass.gov (Global: 4,269^th place; English: 2,127^th place)

mysanantonio.com (Global: 3,758^th place; English: 1,989^th place)

nbcnews.com (Global: 156^th place; English: 101^st place)

nber.org (Global: 3,811^th place; English: 2,424^th place)

newyorker.com (Global: 191^st place; English: 122^nd place)

nih.gov (Global: 5^th place; English: 5^th place)

npr.org (Global: 114^th place; English: 75^th place)

ny.gov (Global: 1,386^th place; English: 642^nd place)

nytimes.com (Global: 7^th place; English: 7^th place)

purdue.edu (Global: 1,391^st place; English: 979^th place)

reuters.com (Global: 38^th place; English: 30^th place)

semafor.com (Global: low place; English: 6,209^th place)

si.edu (Global: 256^th place; English: 197^th place)

slate.com (Global: 409^th place; English: 260^th place)

stamfordadvocate.com (Global: low place; English: 6,249^th place)

statista.com (Global: 1,214^th place; English: 1,277^th place)

statnews.com (Global: 7,413^th place; English: 4,542^nd place)

theguardian.com (Global: 16^th place; English: 11^th place)

thehill.com (Global: 469^th place; English: 252^nd place)

uconn.edu (Global: 5,263^rd place; English: 3,154^th place)

usatoday.com (Global: 55^th place; English: 36^th place)

wbur.org (Global: 3,044^th place; English: 1,526^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

worldcat.org (Global: 4^th place; English: 4^th place)